Technical Analysis for IFRX - InflaRx N.V.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New 52 Week Closing High | Bullish | 3.92% | |
| Calm After Storm | Range Contraction | 3.92% | |
| Upper Bollinger Band Walk | Strength | 3.92% | |
| Inside Day | Range Contraction | 3.92% | |
| Wide Bands | Range Expansion | 3.92% | |
| Above Upper BB | Strength | 3.92% | |
| Gapped Up | Strength | 3.92% | |
| Upper Bollinger Band Touch | Strength | 3.92% | |
| New Uptrend | Bullish | 10.42% | |
| Volume Surge | Other | 10.42% |
| Alert | Time |
|---|---|
| Up 3% | about 1 hour ago |
| 60 Minute Opening Range Breakout | about 1 hour ago |
| Up 2% | about 2 hours ago |
| Down 3% | about 2 hours ago |
| Down 2 % | about 3 hours ago |
Get a Trading Sidekick!
- Earnings date: 08/08/2024
InflaRx N.V. Description
Inflarx NV, formerly Fireman BV, is a holding company for InflaRx GmbH, a Germany-based clinical-stage biopharmaceutical company. The Company's primary focus is on the development of monoclonal antibodies targeting activation products of the complement system for application in the treatment of life-threatening inflammatory diseases. Its lead product candidate, IFX-1, is an intravenously delivered first-in-class anti-C5a monoclonal antibody, undergoing Phase II clinical trial for the treatment of Hidradenitis Suppurativa (HS), a rare and chronic debilitating systemic inflammatory skin disease, and entering Phase II clinical trial for the treatment of ANCA-associated vasculitis (AAV) and other rare autoimmune diseases. The Company's product pipeline also includes IFX-2, which is in preclinical development.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Biopharmaceutical Immunology Immune System Autoimmune Disease Antibodies Clinical Development Monoclonal Antibodies Monoclonal Antibody Inflammatory Diseases Complement System Hidradenitis Suppurativa C5a
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 2.44 |
| 52 Week Low | 1.165 |
| Average Volume | 153,661 |
| 200-Day Moving Average | 1.53 |
| 50-Day Moving Average | 1.57 |
| 20-Day Moving Average | 1.66 |
| 10-Day Moving Average | 1.75 |
| Average True Range | 0.21 |
| RSI (14) | 66.56 |
| ADX | 25.62 |
| +DI | 28.54 |
| -DI | 14.56 |
| Chandelier Exit (Long, 3 ATRs) | 1.80 |
| Chandelier Exit (Short, 3 ATRs) | 2.09 |
| Upper Bollinger Bands | 2.01 |
| Lower Bollinger Band | 1.31 |
| Percent B (%b) | 1.05 |
| BandWidth | 41.73 |
| MACD Line | 0.10 |
| MACD Signal Line | 0.06 |
| MACD Histogram | 0.0444 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 2.42 | ||||
| Resistance 3 (R3) | 2.42 | 2.28 | 2.36 | ||
| Resistance 2 (R2) | 2.28 | 2.18 | 2.28 | 2.34 | |
| Resistance 1 (R1) | 2.16 | 2.12 | 2.22 | 2.17 | 2.32 |
| Pivot Point | 2.03 | 2.03 | 2.06 | 2.03 | 2.03 |
| Support 1 (S1) | 1.90 | 1.93 | 1.97 | 1.91 | 1.76 |
| Support 2 (S2) | 1.77 | 1.87 | 1.77 | 1.74 | |
| Support 3 (S3) | 1.65 | 1.77 | 1.72 | ||
| Support 4 (S4) | 1.66 |
